Product Recalls in South Carolina

Product recalls affecting South Carolina — including food, drugs, consumer products, medical devices, and vehicles distributed to South Carolina. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,672 recalls have been distributed to South Carolina in the last 12 months.

51,854 total recalls
2,672 in last 12 months

Showing 1184111860 of 13,686 recalls

DrugJanuary 24, 2014· Teva Pharmaceuticals USA

Recalled Item: Teva Hydroxyzine Pamoate Capsules Recalled by Teva Pharmaceuticals USA Due...

The Issue: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2014· Teva Pharmaceuticals USA

Recalled Item: Teva Ethambutol Hydrochloride Tablets Recalled by Teva Pharmaceuticals USA...

The Issue: CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2014· MyNicNaxs, Inc.

Recalled Item: Pill for weight reduction Recalled by MyNicNaxs, Inc. Due to Undeclared Active

The Issue: Marketed Without an Approved NDA/ANDA: Product was found to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 24, 2014· Teva Pharmaceuticals USA

Recalled Item: Teva Dextroamphetamine Saccharate Recalled by Teva Pharmaceuticals USA Due...

The Issue: CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 24, 2014· MyNicNaxs, Inc.

Recalled Item: SlimEasy Herbs Capsule Recalled by MyNicNaxs, Inc. Due to Undeclared Active

The Issue: Marketed Without an Approved NDA/ANDA: Product was found to contain...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 22, 2014· Fresenius Kabi USA, LLC

Recalled Item: Heparin Sodium Injection Recalled by Fresenius Kabi USA, LLC Due to...

The Issue: Subpotent; 18 month time point

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· Ranbaxy Inc.

Recalled Item: Atorvastatin Calcium Tablets Recalled by Ranbaxy Inc. Due to Presence of...

The Issue: Presence of Foreign Tablets: A product complaint was received by a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Cooling Eye Drops Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Dry Eye Recalled by The Mentholatum Co. Due to Lack of Assurance of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 16, 2014· The Mentholatum Co.

Recalled Item: ROHTO Redness Relief Recalled by The Mentholatum Co. Due to Lack of...

The Issue: Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 15, 2014· Watson Laboratories Inc

Recalled Item: Hydrocodone Bitartrate and Acetaminophen Tablets USP Recalled by Watson...

The Issue: Failed Tablet/Capsule Specifications; Product contains broken tablets.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2014· Mylan Pharmaceuticals Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Pharmaceuticals Inc. Due to...

The Issue: Subpotent Drug: Assay results obtained during stability testing for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 14, 2014· Traxx International Corp

Recalled Item: Guaifenesin USP Recalled by Traxx International Corp Due to Presence of...

The Issue: Presence of Foreign Matter: Guaifenesin API powder is being recalled due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugJanuary 13, 2014· HUMAN SCIENCE FOUNDATION

Recalled Item: PRO ArthMax Dietary Supplement tablets Recalled by HUMAN SCIENCE FOUNDATION...

The Issue: Marketed without an Approved NDA/ANDA; FDA analysis found the product to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: Defective Container; some of the outer laminate foil pouches allowed in air...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugJanuary 13, 2014· Merck & Co Inc

Recalled Item: Liptruzet (ezetimibe and atorvastin) tablets Recalled by Merck & Co Inc Due...

The Issue: This recall of LIPTRUZET is being initiated due to packaging defects. Some...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund